B.C. suspends use of Novartis flu vaccine as precautionary measure

VICTORIA – B.C. is heeding a Health Canada recommendation to suspend the use of a flu vaccine made by the pharmaceutical firm Novartis.

The B.C. Centre for Disease Control has issued notice to all provincial health authorities advising them to stop using products sold in Canada as Agriflu and Fluad.

The precautionary measure was taken based on reports of small clumping material that was noticed in some batches of the vaccines in the Italian plant where it is produced.

B.C.’s ministry of health says people who have already been vaccinated don’t need to worry, as there have been no safety concerns reported in relation to the vaccines to date.

The Novartis products comprise about 30 per cent of B.C.’s provincial flu vaccine supply.

The ministry says provincial public health officials are working with other experts across Canada this weekend to figure out what steps should be taken next for public vaccination programs.

News from © The Canadian Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

The Canadian Press

The Canadian Press is Canada's trusted news source and leader in providing real-time, bilingual multimedia stories across print, broadcast and digital platforms.